Arctic Bioscience AS (OSL: ABS)
Norway
· Delayed Price · Currency is NOK 13.50
-0.80 (-5.59%)
Aug 30, 2024, 4:26 PM CET
Arctic Bioscience AS Market Cap
Arctic Bioscience AS has a market cap or net worth of 342.49 million as of August 30, 2024. Its market cap has increased by 40.63% in one year.
Market Cap
342.49M
Enterprise Value
264.94M
Revenue
33.76M
Ranking
n/a
PE Ratio
n/a
Stock Price
13.50
Market Cap Chart
Since February 24, 2021, Arctic Bioscience AS's market cap has decreased from 668.24M to 342.49M, a decrease of -48.75%. That is a compound annual growth rate of -17.32%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 30, 2024 | 342.49M | 28.57% |
| Dec 29, 2023 | 266.38M | -7.39% |
| Dec 30, 2022 | 287.63M | -33.50% |
| Dec 30, 2021 | 432.53M | -35.27% |
| Feb 24, 2021 | 668.24M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Medistim ASA | 3.02B |
| Nordhealth AS | 2.93B |
| Nykode Therapeutics AS | 2.16B |
| Photocure ASA | 1.51B |
| Carasent ASA | 1.31B |
| ArcticZymes Technologies ASA | 1.01B |
| Hofseth BioCare ASA | 842.72M |
| Gentian Diagnostics ASA | 809.67M |